Who Is James Dacombe, Europe's Youngest Self-Made Billionaire at 25?
Summarized and contextualized by DistantNews.
At a glance
- British entrepreneur James Dacombe, 25, has become one of Europe's youngest self-made billionaires by founding the AI chip company Olix.
- Olix raised $312 million in August 2026, valuing the company at $3.3 billion, with investors including Arm and Netflix co-founder Reed Hastings.
- Dacombe previously founded a neurotechnology company, CoMind, at age 17, and his career path bypasses traditional university education.
At just 25, British entrepreneur James Dacombe has achieved billionaire status, a remarkable feat accomplished outside the conventional university-to-corporate pipeline. Dacombe, who left school as a teenager, first founded a brain-monitoring company at 17 and has now turned his focus to artificial intelligence chips.
His latest venture, London-based Olix, has propelled him into the ranks of Europe's youngest self-made billionaires. The company's valuation soared to $3.3 billion following a recent funding round that secured $312 million in August 2026. Key investors in this round included chip designer Arm, quantitative trading firm Hudson River Trading, and Netflix co-founder Reed Hastings, with the round led by New York investment firm Fundomo.
Dacombe established Olix in 2024, with the company concentrating on developing specialized chips engineered for more efficient AI model execution. This positions Olix among a growing cohort of startups aiming to challenge Nvidia's current dominance in the AI infrastructure market.
Dacombe's journey began in Harrogate, North Yorkshire, where he developed an early passion for programming. After building websites and apps as a teen, he ventured into neurotechnology with CoMind at 17, focusing on non-invasive brain-monitoring. He opted to forgo formal higher education to dedicate himself to his entrepreneurial pursuits, a path later supported by the Thiel Fellowship, which encourages young individuals to pursue ambitious projects outside traditional academic structures. CoMind has since raised approximately $100 million and conducted trials at St Bartholomew's Hospital in London.
The era of a single Nvidia chip handling every AI task was over.
Originally published by Tempo. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.